NEW YORK (Genomeweb News) – The board of directors of PerkinElmer has declared a quarterly dividend of $.07 per share.

The dividend is payable on May 7 to shareholders of record as of the close of business on April 16.

PerkinElmer is scheduled to release its fourth-quarter and full-year 2009 results on Feb. 4. Analysts expect, on average, the firm to report Q4 revenues of $479.5 million and earnings per share of $.41.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.